Trump SKYROCKETS Prescription Prices
Bold moves or reckless gambles? A look at Trump’s second-term health policies.
Donald Trump has stormed back into the White House, and he isn’t wasting any time shaking up the nation’s healthcare system. In just a matter of days, his administration has unleashed a flurry of executive orders that cut deep into the fabric of public health, reproductive rights, and drug affordability. For his loyalists, it’s a return to the bold, no-compromise leader they revere. For his critics, it’s an alarming escalation that prioritizes ideology and corporate interests over the health of millions.
These healthcare orders hit hard, targeting everything from women’s reproductive rights to the global health stage. They silence federal health agencies, dismantle efforts to address inequality in pandemic recovery and walk away from global partnerships just as the world faces mounting health challenges. For better or worse, Trump is flexing his power to force everyone to sit up and take notice.
The Executive Orders: A Breakdown
Reinstating Anti-Abortion Policies
Trump’s reinstatement of the Mexico City Policy—the infamous “Global Gag Rule”—slashes federal funding to international organizations that provide or even talk about abortion services. At home, he doubled down on enforcing the Hyde Amendment, which blocks federal dollars from covering abortions and pardoned anti-abortion activists convicted of blocking clinic access.
Withdrawal from the World Health Organization (WHO)
Trump made good on his grudge against the WHO, formally pulling the U.S. out of the global health body. He blames the organization for botching the COVID-19 pandemic and accuses it of bowing to China’s influence.
Rescinding Drug Price Reforms
In a move that stunned even some of his supporters, Trump overturned Biden-era reforms that capped drug prices for Medicare and Medicaid. These reforms aimed to rein in the pharmaceutical industry’s unchecked profits, but their repeal could send prescription costs skyrocketing for seniors and low-income families.
Silencing Federal Health Agencies
Trump has gone beyond criticizing the CDC and FDA—he’s gagged them entirely. Federal health agencies have been ordered to cease external communications. There will be no more public updates, no participation in planned conferences, and no publishing of critical resources like the CDC’s Morbidity and Mortality Weekly Report (MMWR), a lifeline for healthcare professionals.
Revoking the COVID-19 Health Equity Task Force
Created under Biden, this task force aimed to address the devastating impact of the pandemic on marginalized communities. Trump’s decision to scrap it signals a full pivot away from equity-based public health efforts, as well as ending research into virus-related research.
The Coffman Chronicle is powered by YOU—no billionaires, no corporate overlords. Help us keep exposing the BS, delivering sharp insights, and keeping you informed.
For just $8 a month or $80 a year, you can fuel the fight and be part of the movement .
Not ready to subscribe? No worries, chaos loves company, and you're always welcome. But if you’re fired up to keep us loud, proud, and unfiltered, smash that subscribe button now!
A Darker, Harder Line Than Before
Trump’s first term offered plenty of fireworks, but this new wave of executive orders is a different beast. While some actions, like reinstating the Global Gag Rule, feel like predictable nods to his conservative base, other moves push well past the limits of his earlier presidency.
Escalation: The Public Health Gag Order
Silencing federal health agencies isn’t just an attack on the “bureaucratic swamp” Trump rails against—it’s a shot at the core of public health itself. The CDC’s MMWR has been an indispensable resource for decades, offering vital data on disease outbreaks, vaccination rates, and other public health trends. Healthcare providers now face the grim reality of operating without this critical guidance.
And it doesn’t stop there. By banning health officials from attending conferences, Trump is isolating U.S. health experts from global conversations on emerging threats like antimicrobial resistance and new infectious diseases. It’s an alarming step back that critics argue leaves the country unprepared for the next big health crisis.
Contradictions: The Drug Price Reversal
Perhaps the most head-scratching move of all is Trump’s rollback of drug price reforms. During his first term, he cast himself as a populist warrior against Big Pharma, promising to lower costs for everyday Americans. This reversal directly undermines that legacy and smacks of capitulation to corporate interests. For seniors on fixed incomes and families scraping by, it’s a bitter pill to swallow. This follows his rescinding of several components of the Inflation Reduction Act, which allowed Medicare to negotiate prices on key drugs just days after it went into effect.
Campaign Promises vs. Policy Reality
Trump campaigned on a populist, nationalist platform in 2024, vowing to slash healthcare costs and put America first. But his actions paint a more complicated picture.
What He Delivered
Reproductive Rights: Trump is delivering on his promises to evangelical voters by reinstating anti-abortion policies and flexing his muscle on cultural issues. However, this directly counters his previous position of leaving abortion oversight to the states.
Global Sovereignty: His withdrawal from the WHO aligns with his “America First” rhetoric and his disdain for multilateral organizations.
Where He Fell Short
Affordable Healthcare: Rescinding drug price caps betrays his pledge to make healthcare more affordable. This move risks alienating working-class voters who looked to him for relief from skyrocketing medical costs. He’s promised a new healthcare plan for years but has yet to deliver as he continues to threaten to end the Affordable Care Act.
Transparency: Trump’s populist appeal relied on empowering voters with the truth. Gagging health agencies and stifling communication betray that ethos, leaving Americans in the dark about critical public health information.
Winners and Losers
Winners
Big Pharma: Pharmaceutical companies stand to rake in billions with drug price reforms off the table.
Anti-Abortion Advocates: Trump’s actions on abortion are a clear victory for his socially conservative base. In addition, he delivered pardons to several anti-abortion activists.
Isolationists: For those who see global organizations as threats to U.S. sovereignty, withdrawing from the WHO is a long-awaited win.
Losers
Everyday Americans: The gagging of health agencies and the rollback of drug price reforms hit hardest on seniors, low-income families, and communities of color.
Medical Professionals: Doctors, nurses, and researchers are now cut off from essential public health data, making their jobs harder.
The World: Trump’s retreat from the WHO has ripple effects far beyond the U.S., threatening vaccination campaigns and global pandemic preparedness.
Global Reaction: Outrage and Uncertainty
The global community hasn’t minced words about Trump’s healthcare orders. Leaders in Europe and Africa have condemned the U.S. withdrawal from the WHO as reckless and shortsighted. WHO officials warn that without U.S. funding, key programs like polio eradication and pandemic response could stall, leaving millions at risk.
Meanwhile, Trump’s critics at home warn that ceding the U.S. leadership role in global health leaves a vacuum that rivals like China are eager to fill.
Conclusion
Donald Trump’s healthcare executive orders are more than a gamble—bold enough to energize his core supporters but divisive enough to spark outrage at home and abroad. America’s healthcare future is on a collision course with more than controversy, and the fallout will shape the nation’s health—and Trump’s legacy—for years to come. Who pays the price? We all do, perhaps even with our lives.
Well done peice!!!
I wonder if the Mario Bros are taking notice...